Recently, Guangzhou Pharmaceutical Group held the 2024 Economic Work Conference at Baiyunshan Pharmaceutical General Factory to comprehensively summarize the work achievements in 2023, study and judge the economic situation, and scientifically deploy the key work of the 2024 "Digital Economy Year". Chen Dejun, Secretary of the Party Committee and Director of Guangzhou State-owned Assets Supervision and Administration Commission, attended the meeting. Li Chuyuan, Secretary of the Party Committee and Chairman of Guangzhou Pharmaceutical Group, Yang Jun, Deputy Secretary of the Party Committee, Vice Chairman and General Manager, and other middle and senior managers of the group and listed companies, as well as the leadership team of affiliated enterprises attended the meeting. Cheng Ning, executive deputy general manager of Guangzhou Pharmaceutical Group, presided over the meeting, and the meeting was held to all subsidiaries of the group through live broadcast. 
At the 2023 "Double Effect Improvement Year" Fruitful Commendation and Advanced Motivational Meeting, Yang Jun, on behalf of the management team of Guangzhou Pharmaceutical Group, summarized the development in 2023 and made specific work arrangements for 2024. In 2023, GPC will thoroughly study and implement the spirit of the 20th National Congress of the Communist Party of China, carry out theme education, thoroughly study, publicize and implement the spirit of the important speeches and important instructions of the General Secretary of the Communist Party of China during his inspection of Guangdong, and focus on the specific deployment of the "1310" of the Provincial Party Committee and the "1312" ideas and measures of the Municipal Party Committee, and make every effort to promote the "double effect improvement" of the company's operating efficiency and economic benefits. Yang Jun pointed out that in 2023, the growth rate of GPC's economic indicators will be stronger than the national, provincial and municipal GDP growth rate and industry growth rate, and there will be many bright spots in production and operation, scientific research and innovation, major project construction, digital transformation, international cooperation, enterprise reform, etc., and the industry status and international influence have been newly improved. 
2024 marks the 75th anniversary of the founding of the People's Republic of China and a crucial year for the implementation of the 14th Five-Year Plan. Yang Jun further mobilized the whole group to keep in mind the entrustment, be grateful and forge ahead, firmly grasp the opportunities of industrial development, accelerate the creation of new quality productivity, and achieve a new leap in 12 projects, including digital transformation, world-class benchmarking, scientific and technological self-reliance and self-reliance, industrial space expansion, superstar varieties, new Kangmei, Baiyun toothpaste, rural industry revitalization, Xinjiang Jiashi Xinmei, international market development, risk control, and talent strengthening enterprises. 
In order to commend the advanced and set an example, the conference commended the 16 winning units of the 2023 "Double Effect Improvement Year" 100-point labor competition, as well as 47 comprehensive management projects and 72 scientific and technological innovation projects, to further stimulate the high morale of the majority of cadres and workers. 
At the meeting, Li Chuyuan signed the 2024 main responsibility letter for the construction of party style and clean government and confidentiality work with the representative of the head of the party organization of the subordinate enterprise; Yang Jun signed the 2024 Economic Responsibility Letter with Li Hong, general manager of the listed company; Li Hong signed the 2024 Economic Responsibility Letter with the heads of the four major sectors. 
At the signing of the letter of responsibility, the General Pharmaceutical Factory, Mingxing Company, Chemical Pharmaceutical Factory, Wanglaoji Health Company, Pharmaceutical Company, Caizhilin Pharmaceutical, Medical Investment Company, and Kangmei Pharmaceutical respectively introduced the work highlights in 2023 and the work plan for 2024. The Group's Science and Technology Management Department introduced the scientific research and innovation work and the next plan, and the Group's Strategic Development Department introduced the work of "Double Effect Improvement". 
The speakers also discussed the group's work report in groups, had a warm exchange on the work experience in 2023 and the work ideas and suggestions in 2024, and reported the group discussion on the spot, making suggestions for the high-quality development of the group.
Group discussion and report: Promote the work of "Digital Economy Year" with high quality, and rebuild a new Guangzhou Pharmaceutical with the hard work of "Second Entrepreneurship", "As the main enterprise of Guangzhou Biomedicine, we must take the initiative to shoulder the responsibility of state-owned enterprises, take the lead in the goal, take the lead in the responsibility, and make contributions to the task, actively look for future growth points, and strive to create a new 'new Guangzhou Medicine'! In his speech, Li Chuyuan pointed out that in 2023, in the face of extremely unusual development pressures and risks and challenges, GPC has shown new responsibilities and new achievements, and there are three experiences worth carrying forward: first, gathering the power of gratitude and forging ahead; the second is to carry forward the spirit of daring to fight and being able to fight; The third is to consolidate the foundation of party building and strengthening enterprises. Li Chuyuan also pointed out that the next step is to strengthen confidence, grasp the new outlet of healthy consumption and digital economy, shoulder the new responsibility of industrial development, boldly plan, work boldly, and boldly break through, and strive to create a "new Guangzhou Medicine" to promote Guangzhou's biomedical and health industry to achieve a high-quality leap. Li Chuyuan emphasized eight key tasks in 2024: First, build digital transformation and build smart general medicine. Give full play to the institutional and institutional advantages of the Digital Economy Research Institute for the establishment of new businesses, and unswervingly follow the development path of the digital economy with the characteristics of Guangzhou Medicine. The second is to develop new quality productive forces and build science and technology and medicine. Seize the opportunity of favorable policies and industrial innovation, and highlight forward-looking, effective and supportive in scientific research work. The third is to seize the new consumer demand and build a brand of Guangyao. Grasp the incremental market under the new consumption model and actively adapt to the new characteristics of consumption. The fourth is to promote the development of new Kangmei and build a promising general medicine. Help "New Kangmei" to enhance the competitiveness of the enterprise and become a listed company with stable operation, standardized operation and excellent performance. Fifth, accelerate the international expansion and build an international general medicine. Focusing on the new positioning of "one point, two places", we will continue to deepen the cooperation between Guangdong, Hong Kong and Macao in the pharmaceutical and health industries, and accelerate the development of international business. Sixth, the implementation of the "Millions of Millions Project" and the construction of love and medicine. We will continue to implement the requirements of the "five major grasps" of the provincial party committee with the "number one project", promote the cooperation between the east and the west, aid Xinjiang and Tibet, and counterpart assistance, and strive to build the rural "native products" into a fashion industry with the integrated development of primary, secondary and tertiary industries. Seventh, it is a world-class benchmark and a high-efficiency general medicine. In accordance with the requirements of the new round of deepening and upgrading of state-owned enterprise reform, we will build "four new" modern new state-owned enterprises around "strong management, strong party building, and strong talents". Eighth, insist on strengthening the root and casting the soul and building a red medicine. Adhere to the party's leadership, strengthen party building, and integrate the party's leadership into all aspects of corporate governance.
Director Chen Dejun highly affirmed the achievements and spirit of GPC in the past year, encouraged GPC to continue to strive for new advantages in development, and put forward the following requirements: to strengthen the party building of state-owned enterprises and promote the organic integration of party building and production and operation. It is necessary to speed up scientific research and innovation, deepen scientific research cooperation with universities and institutes, and promote more scientific research achievements to be implemented in Guangzhou. Deepen the reform of state-owned enterprises and fully release the vitality of market-oriented development of enterprises. Optimize brand building, continue to revitalize time-honored brands, and actively explore the international market. Promote digital transformation and promote the integration of digitalization into production, marketing, decision-making and other links.
The more you know, the more you do. In 2024, under the strong leadership of the provincial party committee and the municipal party committee and the municipal party committee, Guangzhou Pharmaceutical Group will be closely united around the first comrade as the core, with the "vanguard" taking the lead, the "leader" indomitable drive, and the "locomotive" momentum of a day, strengthening confidence, forging ahead, working hard and taking responsibility, and fully implement the work deployment of the group's "digital economy year", serve the "stability" of the whole city and the province with the "stability" of Guangzhou Medicine, and help the whole city and the province with the "progress" of Guangzhou Medicine"Progress", towards the goal of building GPC into a world-class comprehensive pharmaceutical and health group with vigorous development of the four major sectors of Great Southern Medicine, Big Health, Big Commerce and Big Medical, and make new and greater contributions to helping Guangzhou realize the new vitality of the old city with high quality and make new and greater contributions to the "four new and brilliant"! Contributed by**: Guangzhou Pharmaceutical Group.